Published in Front Physiol on February 24, 2016
NZ-GMP Approved Serum Improve hDPSC Osteogenic Commitment and Increase Angiogenic Factor Expression. Front Physiol (2016) 0.75
Chasing the recipe for a pro-regenerative immune system. Semin Cell Dev Biol (2016) 0.75
Application of Stem Cells in Oral Disease Therapy: Progresses and Perspectives. Front Physiol (2017) 0.75
Monitoring Notch Signaling-Associated Activation of Stem Cell Niches within Injured Dental Pulp. Front Physiol (2017) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Integrins: bidirectional, allosteric signaling machines. Cell (2002) 36.25
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A (2000) 11.41
Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A (2011) 9.57
Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron (2011) 8.06
Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet (2004) 7.84
Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol (2001) 7.20
Stem cell properties of human dental pulp stem cells. J Dent Res (2002) 5.57
Stimulation of bone formation in vitro and in rodents by statins. Science (1999) 5.55
Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med (2009) 5.50
Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials (2006) 5.22
Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol (2007) 4.53
Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med (2000) 4.25
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood (2001) 4.22
Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development (1996) 3.91
BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev (1995) 3.84
TAp63 prevents premature aging by promoting adult stem cell maintenance. Cell Stem Cell (2009) 3.15
Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J Endod (2008) 2.95
Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol (2008) 2.79
Regenerative endodontics: a review of current status and a call for action. J Endod (2007) 2.68
Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum (2009) 2.64
Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest (2002) 2.59
Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther (2004) 2.55
Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell (2013) 2.45
Consequences of knocking out BMP signaling in the mouse. Genesis (2003) 2.36
A reevaluation of integrins as regulators of angiogenesis. Nat Med (2002) 2.36
Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J Mol Cell Cardiol (2006) 2.33
Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res (2007) 2.26
Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect. Bone (2012) 2.24
A new population of human adult dental pulp stem cells: a useful source of living autologous fibrous bone tissue (LAB). J Bone Miner Res (2005) 2.24
A brief definition of regenerative medicine. Regen Med (2008) 2.22
Human postnatal dental pulp cells co-differentiate into osteoblasts and endotheliocytes: a pivotal synergy leading to adult bone tissue formation. Cell Death Differ (2007) 2.20
Dental pulp tissue engineering with stem cells from exfoliated deciduous teeth. J Endod (2008) 2.19
Stem-cell-based tissue engineering of murine teeth. J Dent Res (2004) 2.17
Recent advances in bone tissue engineering scaffolds. Trends Biotechnol (2012) 2.13
Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell (2009) 2.10
Mice lacking Bmp6 function. Dev Genet (1998) 2.09
Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials (2005) 1.89
Toward delivery of multiple growth factors in tissue engineering. Biomaterials (2010) 1.87
Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med (2008) 1.77
Bone morphogenetic proteins in clinical applications. ANZ J Surg (2007) 1.75
Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. J Bone Miner Res (2009) 1.68
Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A (2009) 1.67
VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res (2006) 1.63
Bone morphogenetic protein 2 therapy for craniofacial surgery. J Craniofac Surg (2008) 1.56
Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med (2008) 1.54
Generation of different fates from multipotent muscle stem cells. Development (2002) 1.51
Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche. Curr Opin Cell Biol (2012) 1.51
Developing safe therapies from human pluripotent stem cells. Nat Biotechnol (2009) 1.48
Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol (2009) 1.46
Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 2: Bone graft, implant and reconstructive surgery. Curr Pharm Biotechnol (2012) 1.45
Mobilization of endogenous stem cell populations enhances fracture healing in a murine femoral fracture model. Cytotherapy (2013) 1.44
Mechanical loading history and skeletal biology. J Biomech (1987) 1.44
The aging hippocampus: interactions between exercise, depression, and BDNF. Neuroscientist (2011) 1.43
The stem cell niche in regenerative medicine. Cell Stem Cell (2012) 1.39
In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng (2007) 1.35
Citrate bridges between mineral platelets in bone. Proc Natl Acad Sci U S A (2014) 1.29
Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 1: Periodontal and dentoalveolar surgery. Curr Pharm Biotechnol (2012) 1.29
An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. Int J Mol Sci (2014) 1.27
To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem (2004) 1.27
Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res (2004) 1.25
Immune problems in central nervous system cell therapy. NeuroRx (2004) 1.21
In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res (2008) 1.21
Recombinant human osteogenic protein-1 (OP-1) stimulates periodontal wound healing in class III furcation defects. J Periodontol (1998) 1.21
Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater (2008) 1.20
Human dental pulp stem cells with highly angiogenic and neurogenic potential for possible use in pulp regeneration. Cytokine Growth Factor Rev (2009) 1.19
Histone deacetylase inhibition with valproic acid downregulates osteocalcin gene expression in human dental pulp stem cells and osteoblasts: evidence for HDAC2 involvement. Stem Cells (2014) 1.19
Ultrasound for fracture healing: current evidence. J Orthop Trauma (2010) 1.17
Photoactivation of endogenous latent transforming growth factor-β1 directs dental stem cell differentiation for regeneration. Sci Transl Med (2014) 1.16
Role of mechanical factors in fate decisions of stem cells. Regen Med (2011) 1.15
Emerging use of stem cells in regenerative medicine. Biochem J (2010) 1.14
Dental pulp stem cells: state of the art and suggestions for a true translation of research into therapy. J Dent (2014) 1.14
Collagen for bone tissue regeneration. Acta Biomater (2012) 1.13
Bone tissue engineering with porous hydroxyapatite ceramics. J Artif Organs (2005) 1.11
Stimulatory effect on bone formation exerted by a modified chitosan. Biomaterials (1994) 1.11
The Important Role of Osteoblasts and Citrate Production in Bone Formation: "Osteoblast Citration" as a New Concept for an Old Relationship. Open Bone J (2012) 1.09
Three years after transplants in human mandibles, histological and in-line holotomography revealed that stem cells regenerated a compact rather than a spongy bone: biological and clinical implications. Stem Cells Transl Med (2013) 1.06
PDGF-B gene therapy accelerates bone engineering and oral implant osseointegration. Gene Ther (2009) 1.06
Repair of calvarial defects with customised tissue-engineered bone grafts II. Evaluation of cellular efficiency and efficacy in vivo. Tissue Eng (2003) 1.05
The use of injectable sonication-induced silk hydrogel for VEGF(165) and BMP-2 delivery for elevation of the maxillary sinus floor. Biomaterials (2011) 1.05
Composite chitosan/nano-hydroxyapatite scaffolds induce osteocalcin production by osteoblasts in vitro and support bone formation in vivo. Tissue Eng Part A (2009) 1.04
Stimulation of reparative dentin formation by ex vivo gene therapy using dental pulp stem cells electrotransfected with growth/differentiation factor 11 (Gdf11). Hum Gene Ther (2004) 1.03
Review paper: behavior of ceramic biomaterials derived from tricalcium phosphate in physiological condition. J Biomater Appl (2008) 1.02
Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid--an experimental study in rats. Biomaterials (2008) 1.01
Fibroin scaffold repairs critical-size bone defects in vivo supported by human amniotic fluid and dental pulp stem cells. Tissue Eng Part A (2012) 1.01
VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo. Eur Cell Mater (2010) 1.00
A comparative analysis of the osteogenic effects of BMP-2, FGF-2, and VEGFA in a calvarial defect model. Tissue Eng Part A (2012) 1.00
Cellular repair of CNS disorders: an immunological perspective. Hum Mol Genet (2008) 1.00
Preparation of macroporous biodegradable PLGA scaffolds for cell attachment with the use of mixed salts as porogen additives. J Biomed Mater Res (2002) 1.00
Effects of low-intensity ultrasound on chondrogenic differentiation of mesenchymal stem cells embedded in polyglycolic acid: an in vivo study. Tissue Eng (2006) 0.98
VEGF-activated angiogenesis during bone regeneration. J Oral Maxillofac Surg (2005) 0.98
Human neural crest-derived postnatal cells exhibit remarkable embryonic attributes either in vitro or in vivo. Eur Cell Mater (2011) 0.97
Selective activation of sphingosine 1-phosphate receptors 1 and 3 promotes local microvascular network growth. Tissue Eng Part A (2010) 0.96
Three-Dimensional Bioprinting for Regenerative Dentistry and Craniofacial Tissue Engineering. J Dent Res (2015) 0.96
Biomaterials for craniofacial bone engineering. J Dent Res (2014) 0.96
Stromal cell-derived factor-1 significantly induces proliferation, migration, and collagen type I expression in a human periodontal ligament stem cell subpopulation. J Periodontol (2011) 0.95
Microdeletion 20p12.3 involving BMP2 contributes to syndromic forms of cleft palate. Am J Med Genet A (2011) 0.94
Pre-clinical models for oral and periodontal reconstructive therapies. J Dent Res (2009) 0.94